| Original language | English |
|---|---|
| Pages (from-to) | 1191-1192 |
| Number of pages | 2 |
| Journal | Urology |
| Volume | 79 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2012 |
Re: Twardowski et al.: Phase II study of aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer: A California cancer consortium trial (Urology 2010;76:923-926)
Research output: Contribution to journal › Letter › peer-review
2
Scopus
citations